Form 8-K - Current report:
SEC Accession No. 0001193125-25-019277
Filing Date
2025-02-03
Accepted
2025-02-03 16:10:17
Documents
15
Period of Report
2025-02-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d871147d8k.htm   iXBRL 8-K 28863
2 EX-3.1 d871147dex31.htm EX-3.1 32568
3 EX-3.2 d871147dex32.htm EX-3.2 176886
  Complete submission text file 0001193125-25-019277.txt   416113

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mtsr-20250203.xsd EX-101.SCH 2876
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtsr-20250203_lab.xml EX-101.LAB 19481
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtsr-20250203_pre.xml EX-101.PRE 12170
17 EXTRACTED XBRL INSTANCE DOCUMENT d871147d8k_htm.xml XML 3979
Mailing Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007
Business Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007 (212) 784-6595
Metsera, Inc. (Filer) CIK: 0002040807 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42489 | Film No.: 25582602
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)